Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07484191 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Contralateral Claims Study of Clareon Vivity Pro

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 29% 231 → 165 participants
See other at-risk trials from Alcon Research

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 8 words
  2. Enrollment closed, study ongoing
    • Enrollment reduced: 231 → 165 participants
    • Site details revised at 7 of 7 sites
    v5
  3. Study sites: 9 to 7v4
  4. Study description shortened, about 3 wordsv3
  5. Recruitment opened
    • Trial sites expanded: 0 → 9 locations
    • Start date changed from estimate of Apr 2026 to Apr 28, 2026
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Alcon Research
30 trials monitored
See 3 trials at risk
The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.
Trial Details
NCT Number NCT07484191
Lead Sponsor Alcon Research
Conditions
(from sponsor)		 Aphakia, Presbyopia
Related terms Aphakia, Cataract, Presbyopia
Enrollment 165 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov